Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

MBI and Koch agree to exclusive sales rights for REGALIA® Rx and REGALIA® Maxxqrcode

Jun. 2, 2016

Favorites Print
Jun. 2, 2016

Koch Agronomic Services, LLC (Koch), with support from its affiliate, Koch Biological Solutions, LLC, has secured exclusive rights to sell REGALIA® Rx in the U.S. and REGALIA® Maxx in Canada. Koch will market and sell the products for broad-acre agriculture applications. REGALIA® Rx and REGALIA® Maxx are manufactured by Marrone Bio Innovations, Inc. (MBI) and improve crop performance by providing defense against fungal pests. Both products also offer significant plant health benefits.

MBI is a pioneer in the rapidly growing field of biopesticides with multiple product lines already in the market. MBI's products are supported by robust capabilities for discovering, developing and commercializing naturally derived technologies.

"MBI has a proven history of developing biopesticides that offer effective solutions for growers" said Pam Marrone, founder and CEO of Marrone Bio Innovations. "We believe that Koch's broad-acre agriculture experience and ability to bring products to market will provide more growers the ability to increase their yields with REGALIA® Rx and REGALIA® Maxx on broad-acre row crops."

Koch Agronomic Services is dedicated to providing fertilizers to increase plant performance that are grounded in science. Koch Agronomic Services has a broad portfolio of enhanced efficiency fertilizer technologies in both the agricultural and turf & ornamental markets including AGROTAIN® nitrogen stabilizer, SUPERU® fertilizer, POLYON® and DURATION® controlled-release fertilizer and UMAXX® stabilized nitrogen among many others.

Koch Biological Solutions has established a strong discovery platform focused on the identification, development and commercialization of biostimulant products that improve plant performance. The company has several promising biological product candidates in various stages of development.

"We're looking for ways to bring effective, science-based products to the market whether that's through the development of our own products, or through partnerships with innovators like MBI," said Bill Boycott, vice president, biologicals and origination for Koch. "Our goal is to provide effective biologicals for our customers and growers. We are very excited about the technology behind REGALIA® Rx and REGALIA® Maxx."

Additional terms of the deal were not disclosed.


More from AgroNewsChange

Hot Topic More

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  





Subscribe BioEx Biweekly to send news related to your mailbox